Feedback
The current prices are delayed. Login to see live prices.

Jubilant Pharmova Ltd.

(JUBLPHARMA)

801234567899012345678950123456789.9012345678900123456789
+7.20 (+0.81%)
Updated 15:53 28/03 IST
Add
Previous Close: 888.7
Today's low
₹877.50
Today's high
₹904
52 week low
₹538.05
52 week high
₹1,309.9
Open
₹888.7
Prev Close
₹888.7
Volume (shares)
159,955
Total Trading Value
14.22 Cr

Technicals

SMA
Value
Signal
12-SMA
959.14
Bearish
20-SMA
975.18
Bearish
50-SMA
989.81
Bearish
100-SMA
1,077.42
Bearish
200-SMA
964.99
Bearish

Discussions

  •  Mar 13 2:04 PM
Jubilant Pharmova Ltd view for Intraday 13th March #JUBLPHARMA
Resistance 870 Watching above 872 for upside movement......read more

4

1
  •  Jan 7 9:12 PM
(JUBILANT PHARMOVA PVT. LTD.)
(ANALYSIS OF JUBLPHARMA FOR A SHORT TIME)...read more

4

4

  •  Jan 29 8:15 PM
#JUBLPHARMA CAN BE A PERFECT REVERSAL CANDIDATE 💫
TARGET - 1000 💹...read more

4

1
  •  Jan 20 10:39 PM
💸 #JUBLPHARMA READY TO BLAST 💸
ENTRY - 985 🚀...read more

3

  •  Dec 20, 2024 1:31 AM
- Trend: Stock is in a long-term uptrend and consolidati...read more

1

  •  Dec 2, 2024 2:26 PM
INTRADAY TRADE
STOCK-:@JUBLPHARMA...read more

2

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of Jubilant Pharmova Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of Jubilant Pharmova Ltd. is Rs 888.7 as of 28 March 2025.

What is the Market Capitalization of Jubilant Pharmova Ltd. ?

The current market cap of Jubilant Pharmova Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of Jubilant Pharmova Ltd.?

Jubilant Pharmova Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of Jubilant Pharmova Ltd.?

The 52-week high of Jubilant Pharmova Ltd. is Rs 1309.9 and the 52-week low is Rs 538.05
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2025